Calcineurin-inhibitor induced pain syndrome after stem cell transplant-Reference-Cited by-同舟云学术

Calcineurin-inhibitor induced pain syndrome after stem cell transplant

Published:2020-05-20 Issue:9 Volume:61 Page:2230-2233
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Varma Ankur¹,Loya Jacob²,Junaid Hussain Mohammad¹,Don Yun Hyun¹,Gobbi Elizabeth K.³,Reimer Ashley¹,Nathan Sunita¹,Ustun Celalettin¹^ORCID,Muffly Lori²

Affiliation:

1. Division of Hematology, Oncology and Cellular Therapy, Rush University, Chicago, IL, USA;

2. Division of Blood and Marrow Transplantation, Stanford University Medical Center, Stanford, CA, USA;

3. Section of Palliative Care, Rush University, Chicago, IL, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1765235

Reference13 articles.

1. Clinical features of calcineurin inhibitor-induced pain syndrome after allo-SCT

2. Calcineurin Inhibitor-Induced Irreversible Neuropathic Pain after Allogeneic Hematopoietic Stem Cell Transplantation

3. Calcineurin-inhibitor-induced pain syndrome after bone marrow transplantation

4. Calcineurin-inhibitor-induced pain syndrome after a second allogeneic bone marrow transplantation for a child with aplastic anemia

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biobehavioral Research and Hematopoietic Stem Cell Transplantation: Expert Review from the Biobehavioral Research Special Interest Group of the American Society for Transplantation and Cellular Therapy;Transplantation and Cellular Therapy;2021-09

2. Tacrolimus;Reactions Weekly;2020-10